Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Wednesday, June 10, 2015 1:10:00 PM
bullish
## source: finance.yahoo.com
Mon, 08 Jun 2015 11:37:07 GMT ~ Amicus Therapeutics Strengthens Executive Leadership Team
[at noodls] - Adds Two Former Heads of Global Marketing From Leading Rare Disease Companies in Fabry Field Hung Do, Ph.D. Promoted to Chief Science Officer CRANBURY, N.J., June 8, 2015 (GLOBE NEWSWIRE) -- Amicus Therapeutics ...
read full: http://www.noodls.com/view/DC6E338B08CAE81919E32445EF676494A761C0A4
*********************************************************
Mon, 08 Jun 2015 11:30:00 GMT ~ Amicus Therapeutics Strengthens Executive Leadership Team
[GlobeNewswire] - Adds Two Former Heads of Global Marketing From Leading Rare Disease Companies in Fabry Field
read full: http://finance.yahoo.com/news/amicus-therapeutics-strengthens-executive-leadership-113000572.html
*********************************************************
Thu, 04 Jun 2015 10:02:15 GMT ~ AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/150604/fold8-k.html
*********************************************************
Wed, 03 Jun 2015 11:21:10 GMT ~ Amicus Therapeutics Submits Marketing Authorization Application (MAA) for Full Approval of Fabry Monotherapy Galafold(TM) (Migalastat) in European Union
[at noodls] - MAA Submission Under 'Accelerated Assessment' Brand Name Galafold™ Approved by Regulatory Authorities in EU and U.S. ... This is an abstract of the original noodl. To continue reading this document, click ...
read full: http://www.noodls.com/view/8B62861FB912359F54C457842FE8F45E81037D09
*********************************************************
Wed, 03 Jun 2015 11:00:00 GMT ~ Amicus Therapeutics Submits Marketing Authorization Application (MAA) for Full Approval of Fabry Monotherapy Galafold(TM) (Migalastat) in European Union
[GlobeNewswire] - MAA Submission Under "Accelerated Assessment"
read full: http://finance.yahoo.com/news/amicus-therapeutics-submits-marketing-authorization-110000478.html
*********************************************************
$FOLD charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$FOLD company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/FOLD/company-info
Ticker: $FOLD
OTC Market Place: Not Available
CIK code: 0001178879
Company name: Amicus Therapeutics, Inc.
Incorporated In: DE, USA
$FOLD share structure
## source: otcmarkets.com
Market Value: $1,262,153,272 a/o Jun 09, 2015
Shares Outstanding: 96,421,182 a/o Apr 24, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$FOLD extra dd links
Company name: Amicus Therapeutics, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=FOLD+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=FOLD+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=FOLD+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/FOLD/news - http://finance.yahoo.com/q/h?s=FOLD+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/FOLD/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/FOLD/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=FOLD+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/FOLD
DTCC (dtcc.com): http://search2.dtcc.com/?q=Amicus+Therapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Amicus+Therapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Amicus+Therapeutics%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/FOLD
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001178879&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/FOLD/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/FOLD/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=FOLD&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=FOLD
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/FOLD/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=FOLD+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=FOLD+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=FOLD
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=FOLD
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=FOLD+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/FOLD/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=FOLD+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/FOLD.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=FOLD
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/FOLD/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/FOLD
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/FOLD
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/FOLD:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=FOLD
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=FOLD
$FOLD DD Notes ~ http://www.ddnotesmaker.com/FOLD
Recent FOLD News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 09:01:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/03/2024 08:19:15 PM
- UPDATE -- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024 • GlobeNewswire Inc. • 09/03/2024 11:46:15 AM
- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024 • GlobeNewswire Inc. • 09/03/2024 11:05:20 AM
- Amicus Therapeutics Announces Participation at the SSIEM 2024 Annual Symposium • GlobeNewswire Inc. • 09/03/2024 11:00:00 AM
- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024 • GlobeNewswire Inc. • 08/30/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 09:10:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:02:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:01:31 AM
- Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate Updates • GlobeNewswire Inc. • 08/08/2024 11:00:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 12:10:03 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/01/2024 08:25:03 PM
- Amicus Therapeutics to Announce Second Quarter 2024 Financial Results on August 8, 2024 • GlobeNewswire Inc. • 07/30/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 09:01:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 11:54:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 11:53:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 11:52:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 11:49:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 11:47:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 11:46:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 11:44:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 11:41:47 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/07/2024 08:38:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:06:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 08:35:49 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM